Send feedback

EXT1 p.Arg340His

c.1019G>A · rs119103287 · VCV265129

Pathogenic Multiple submitters
Classification
Pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 15 submitters
AlphaMissense
likely pathogenic
0.9881 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
2/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
exostoses, multiple, type 1

Computational evidence

Protein change
AlphaMissense0.9881likely pathogenic ✓ concordant with ClinVar
REVEL0.836moderately pathogenic-leaning
SaProtLLR -8.90tolerated
⇒ AlphaMissense and REVEL call this damaging; SaProt does not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 1.7, phastCons 1
Regional constrainto/e 0.75unconstrained · MANE · 280 kb · p 4.8e-06 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/75,024 alleles
Filtering AF 6.8e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.9e-05%
Overall 0.000248% 4/1,613,978 alleles · very rare exomes 4/1,461,710 · genomes 0/152,268 · joint denominator
Ancestry group Frequency 1 in
African / African-Americangrpmax 0.00133% 75,024
European (non-Finnish) 0.000254% 393,303

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EXT1
Protein
p.Arg340His
Coding
c.1019G>A
MANE Select
NM_000127
dbSNP
rs119103287
Type
single nucleotide variant
Location
chr8:117837145 (GRCh38)
Gene constraint
LOEUF 0.339 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 84.67 · 6 PDB
Residue 340
a UniProt-annotated variant site (in ext1; decreased glucuronosyl-n-acetylglucosaminyl-proteoglycan 4-alpha-n-acetylglucosaminyltransferase activity; decreased n-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; loss of heparan sulfate proteoglycan biosynthetic process; no effect on interaction with ext2; can be integrated in heparan sulfate polymerase complex); a UniProt-annotated variant site (in ext1); a UniProt-annotated variant site (in ext1; loss of heparan sulfate proteoglycan biosynthetic process); a β-strand
Full EXT1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

exostoses, multiple, type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary multiple osteochondromas

For Multiple osteochondromas (Orphanet):

Inheritance
Autosomal dominant
Onset
Childhood
Prevalence
>1 / 1000 (Specific population)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ext1-p-arg340his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown